Form N-CSR FIRST TRUST EXCHANGE-TRA For: Sep 30
Tweet
Share
E-mailNews and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
http://archive.fast-edgar.com/20221209/AHL3S22CZ222L9ZZ2K2U2ZZURVHJZE22Z242
Filed on: December 9, 2022
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fluence Energy, Inc. Reports First Quarter Fiscal 2023 Results
- CUPE: Firing of Athabasca President ‘politics over education’
- EYLEA® (aflibercept) Injection Approved as the First Pharmacologic Treatment for Preterm Infants with Retinopathy of Prematurity (ROP) by the FDA
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
